HOME 201920182017 TOTAAL AML CLINICAL TRIALSGENETICA HEMATOPOIESE IMMUNOLOGIEINNOVATIE LEUKEMIE LYMFOMEN MYELOOM OPINIE ASH TOPPUBLICATIES Dr. M.C. Minnema Phase II study of bortezomib and dexamethasone compared with dexamethasone alone as induction treatment followed by high dose melphalan and autologous SCT in patients with de novo amyloid light chain amyloidosis naar Totaal Terug
